Search - tctmd.com

Displaying 781 - 800 of 4671

Sort: Relevancy | Date

The PACIFIC-AF Study

Podcast TCTMD Talking Points

The PACIFIC-AF Study

April 05, 2023

Around the World, Finances Impact Acute MI Outcomes in Older Adults

News Daily News

Around the World, Finances Impact Acute MI Outcomes in Older Adults

April 04, 2023

Ezetimibe Plus Moderate-Dose Statins May Aid Compliance in the Elderly

News Daily News

Ezetimibe Plus Moderate-Dose Statins May Aid Compliance in the Elderly

Yael L. Maxwell

April 03, 2023

April 2023 News Roundup

News Opinion CV Team Dispatch

April 2023 News Roundup

April 01, 2023

The Evolving Role of Industry and the Interventional Cardiology Fellow

News Opinion Fellow Talk

The Evolving Role of Industry and the Interventional Cardiology Fellow

Poornima Mohan, MBChB

March 31, 2023

Radiation Exposure Highest for Interventional Imagers at Right Waist and Below

News Daily News

Radiation Exposure Highest for Interventional Imagers at Right Waist and Below

Yael L. Maxwell

March 29, 2023

Severe Infections Linked to a Variety of CV Events, Both Acute and Long-term

News Daily News

Severe Infections Linked to a Variety of CV Events, Both Acute and Long-term

March 28, 2023

SCAI/HRS Consensus Document Covers the Ins and Outs of LAAO

News Daily News

SCAI/HRS Consensus Document Covers the Ins and Outs of LAAO

March 28, 2023

High-Intensity Care After Acute HF Pays Off Across LVEF Spectrum: STRONG-HF

News Conference News THT 2023

High-Intensity Care After Acute HF Pays Off Across LVEF Spectrum: STRONG-HF

March 23, 2023

Preliminary Results Suggest Benefit of Splanchnic Nerve Ablation in HFpEF

News Conference News THT 2023

Preliminary Results Suggest Benefit of Splanchnic Nerve Ablation in HFpEF

March 22, 2023

Safety and Efficacy of Istaroxime 1.0 and 1.5 µg/kg/min for Patients With Pre Cardiogenic Shock

Presentation THT 2023

Safety and Efficacy of Istaroxime 1.0 and 1.5 µg/kg/min for Patients With Pre Cardiogenic Shock

Presenter: Gad Cotter

March 22, 2023

Promising Preliminary Results for AccuCinch LV Restoration System in HFrEF

News Conference News THT 2023

Promising Preliminary Results for AccuCinch LV Restoration System in HFrEF

March 21, 2023

Safety and Performance of the Aortix™ Device in Patients With Decompensated Heart Failure and Cardiorenal Syndrome

Presentation THT 2023

Safety and Performance of the Aortix™ Device in Patients With Decompensated Heart Failure and Cardiorenal Syndrome

Presenter: Jennifer Cowger

March 21, 2023

BeAT-HF: Long-term Safety and Outcomes

Presentation THT 2023

BeAT-HF: Long-term Safety and Outcomes

Presenter: Michael Zile

March 21, 2023

Presentation THT 2023

What Are Clinically Meaningful and Practical Pivotal Trial Endpoints for Effectiveness and Safety to Demonstrate an Acceptable Benefit-Risk Profile?

Presenter: Maria Rosa Costanzo

March 20, 2023

14-day End-Organ Safety and Hemocompatibility with theCorInnova Direct Cardiac Compression Device in an Ovine Chronic HeartFailure Model

Presentation THT 2023

14-day End-Organ Safety and Hemocompatibility with theCorInnova Direct Cardiac Compression Device in an Ovine Chronic HeartFailure Model

Presenter: George Letsou

March 20, 2023

SAFE-AAA Flags Ongoing EVAR Device Risk and Urges More Surveillance

News Daily News

SAFE-AAA Flags Ongoing EVAR Device Risk and Urges More Surveillance

March 16, 2023

March 2023 News Roundup

News Opinion CV Team Dispatch

March 2023 News Roundup

March 15, 2023

IMPLEMENT-HF: ‘Virtual’ Stewardship May Help Optimize GDMT in HFrEF

News Conference News ACC 2023

IMPLEMENT-HF: ‘Virtual’ Stewardship May Help Optimize GDMT in HFrEF

March 14, 2023

Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR

News Conference News ACC 2023

Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR

Michael O'Riordan

March 13, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.